Cancer nanotechnology: current status and perspectives

JA Kemp, YJ Kwon - Nano convergence, 2021 - Springer
Modern medicine has been waging a war on cancer for nearly a century with no tangible
end in sight. Cancer treatments have significantly progressed, but the need to increase …

All change in the prostate cancer diagnostic pathway

DJ Lomas, HU Ahmed - Nature reviews Clinical oncology, 2020 - nature.com
Following detection of high levels of serum prostate-specific antigen, many men are advised
to have transrectal ultrasound-guided biopsy in an attempt to locate a cancer. This …

Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

C Rolfo, AF Cardona, M Cristofanilli, L Paz-Ares… - Critical Reviews in …, 2020 - Elsevier
Precision medicine was born with the development of new diagnostic techniques and
targeted drugs, yielding better outcomes in cancer care. With the evolution and increasing …

SelectMDx and multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy: a prospective assessment in a multi …

M Maggi, F Del Giudice, UG Falagario, A Cocci… - Cancers, 2021 - mdpi.com
Simple Summary Prostate-specific antigen and digital rectal examination, used to guide
prostate biopsy, often result in overdiagnosis of indolent prostate cancer (PCa) while …

Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men

RJ Hendriks, MMG van der Leest, B Israël… - Prostate cancer and …, 2021 - nature.com
Background Risk stratification in men with suspicion of prostate cancer (PCa) requires
reliable diagnostic tests, not only to identify high-grade PCa, also to minimize the …

Prediction medicine: biomarkers, risk calculators and magnetic resonance imaging as risk stratification tools in prostate cancer diagnosis

DF Osses, MJ Roobol, IG Schoots - International journal of molecular …, 2019 - mdpi.com
This review discusses the most recent evidence for currently available risk stratification tools
in the detection of clinically significant prostate cancer (csPCa), and evaluates diagnostic …

Prostate cancer liquid biopsy biomarkers' clinical utility in diagnosis and prognosis

M Matuszczak, JA Schalken, M Salagierski - Cancers, 2021 - mdpi.com
Simple Summary In prostate cancer, overdiagnosis and overtreatment is a common problem
for clinicians. Accurate diagnosis and prognosis are essential to avoid unnecessary biopsy …

When tissue is an issue the liquid biopsy is nonissue: a review

J Rodríguez, J Avila, C Rolfo, A Ruíz-Patiño… - Oncology and …, 2021 - Springer
Precision medicine has impacted the field of medical oncology by introducing personalized
therapies, improving all measurable outcomes. This field, in turn, has expanded to obtaining …

Recent advances and future perspectives in the therapeutics of prostate cancer

GL Varaprasad, VK Gupta, K Prasad, E Kim… - … Hematology & Oncology, 2023 - Springer
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading
reason of death. Age, ethnicity, family history, and genetic defects are major factors that …

Magnetic Resonance Imaging, Clinical, and Biopsy Findings in Suspected Prostate Cancer: A Systematic Review and Meta-Analysis

A Haj-Mirzaian, KS Burk, R Lacson, DI Glazer… - JAMA Network …, 2024 - jamanetwork.com
Importance Multiple strategies integrating magnetic resonance imaging (MRI) and clinical
data have been proposed to determine the need for a prostate biopsy in men with suspected …